Addition of bevacizumab to standard therapy improves outcomes in metastatic colorectal cancer
1. Adding bevacizumab to mFOLFOX6 therapy among patients with RAS mutant metastatic colorectal cancer led to an increased rate of ...
1. Adding bevacizumab to mFOLFOX6 therapy among patients with RAS mutant metastatic colorectal cancer led to an increased rate of ...
1. In this prospective propensity score (PS)-matched cohort study, lipophilic statins were found to significantly reduce incidence and mortality of ...
1. In patients undergoing partial hepatectomy, pre-operative CT scans of liver parenchyma revealed less homogenous texture in patients who went ...
Originally published by Harvard Health. What Is It? Liver cancer is the uncontrolled growth of abnormal cells in the liver. The ...
Image: PD 1. Patients whose liver cancers had higher levels of SALL4 had a poorer prognosis. 2. SALL4 could be ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.